Burkitt lymphoma trials in United States

In United States 25 Also abroad 34

25 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Where
Bethesda
Age
18 years to 120 years
People
155
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03223610
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New Haven, New York, Philadelphia, Portland, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
No phaseTaking people
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Where
Atlanta, Aurora, Cincinnati, Houston, Milwaukee, Philadelphia
Age
0 years to 38 years
People
30
Run by
Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06131801
No phaseTaking people
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Where
Chapel Hill
Age
18 years to 120 years
People
15,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643
Phase 1Taking people
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Where
San Francisco
Age
18 years and over
People
36
Run by
C. Babis Andreadis
See details and how to joinNCT04545762
Phase 1/2Taking people
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Where
Chapel Hill, Columbus, Denver, Duarte, Houston, Jacksonville, Los Angeles, Nashville, Portland, Rochester, Valhalla
Age
13 years to 90 years
People
32
Run by
Vironexis Biotherapeutics Inc.
See details and how to joinNCT06533579
Phase 2Taking people
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Where
Valhalla
Age
3 years to 31 years
People
25
Run by
New York Medical College
See details and how to joinNCT02393157
Phase 2Taking people
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
Where
Seattle
Age
18 years and over
People
18
Run by
University of Washington
See details and how to joinNCT07097363
Phase 2Not yet taking people in United States
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
Where
New York
Age
18 years and over
People
43
Run by
AIDS Malignancy Consortium
See details and how to joinNCT07662928
Phase 1/2Taking people
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Where
Fairway, Irvine, Kansas City, Oklahoma City, Orange, Overland Park, Pittsburgh, Westwood
Age
18 years and over
People
50
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07069699
Phase 2Not yet taking people in United States
Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Where
Seattle
People
52
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT07819396
Phase 1Taking people
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Where
Bethesda
Age
18 years to 120 years
People
25
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05389423
Phase 1Taking people
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Where
Palo Alto
Age
18 years and over
People
148
Run by
Stanford University
See details and how to joinNCT06340737
Phase 2Taking people
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Where
Houston
Age
15 years and over
People
42
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT03136146
Phase 1Taking people
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Where
Milwaukee
Age
18 years to 81 years
People
12
Run by
Medical College of Wisconsin
See details and how to joinNCT05990465
Phase 1/2Taking people
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Where
Houston
Age
18 years and over
People
276
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT01371630
No phaseTaking people
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Where
Philadelphia
Age
Up to 25 years
People
50
Run by
Children's Hospital of Philadelphia
See details and how to joinNCT03810196
Phase 2Taking people
Allo HSCT Using RIC and PTCy for Hematological Diseases
Where
Minneapolis
Age
Up to 75 years
People
56
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605
No phaseTaking people
Registry of Older Patients With Cancer
Where
Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
Age
65 years and over
People
3,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825
Phase 2Taking people
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Where
Minneapolis
Age
Up to 60 years
People
300
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974
Phase 2Taking people
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Where
Seattle
Age
6 months and over
People
60
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT04195633
No phaseTaking people
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Where
Milwaukee
Age
0 years to 25 years
People
40
Run by
Medical College of Wisconsin
See details and how to joinNCT05794880
Phase 1/2Taking people
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Where
Valhalla
Age
12 years to 70 years
People
20
Run by
New York Medical College
See details and how to joinNCT04491370
Phase 1Taking people
Study of SGR-1505 in Mature B-Cell Neoplasms
Where
Boston, Buffalo, Canton, Columbus, Dallas, Durham, Gilbert, Hackensack, Milwaukee, Newark, New York, Pompano Beach, Portland, Providence, Seattle, The Bronx
Age
18 years and over
People
98 worldwide
Run by
Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00
No phaseTaking people
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Where
Milwaukee
Age
18 years to 80 years
People
500
Run by
Medical College of Wisconsin
See details and how to joinNCT03375619